Medicines for Patients with Rare Diseases of the Bone-muscle System and Connective Tissue, 4 Lots

KazakhTenders notice for Medicines for Patients with Rare Diseases of the Bone-muscle System and Connective Tissue, 4 Lots. The reference ID of the tender is 89175795 and it is closing on 19 Sep 2023.

100% Secure Payments

Tender Details

  • Country: Ukraine
  • Summary: Medicines for Patients with Rare Diseases of the Bone-muscle System and Connective Tissue, 4 Lots
  • KZT Ref No: 89175795
  • Deadline: 19 Sep 2023
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: UA-2023-09-19-007048-a
  • Purchaser's Detail :
  • Purchaser : DEPARTMENT OF HEALTH OF THE EXECUTIVE BODY OF THE KYIV CITY COUNCIL (KYIV CITY STATE ADMINISTRATION)
    Address: 01001 Ukraine Kyiv region Kyiv City Kyiv Street Porrivna, 19
    Tel.: +380442840810
    Name: Luchkina Kateryna Alexandrovna
    Email :katrin_by@ukr.net

  • Description :
  • Medicines for patients with rare diseases of the bone-muscle system and connective tissue, 4 lots
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
KazakhTenders Features

KazakhTenders Features

Fresh and verified Tenders from Kazakh. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Kazakh in your email inbox.

  Chat with us